Study of possibilities to improve the effectiveness of stress urinary incontinence treatment in menopausal women with an implanted TVT-O sling
DOI:
https://doi.org/10.15574/PP.2025.1(101).6773Keywords:
stress urinary incontinence, sling, pelvic surgery, estrogens, menopausal period, womenAbstract
The issue of urinary disorders in postmenopausal women is receiving significant attention due to its negative impact on quality of life, social activity, and the risk of emotional and sexual dysfunction.
Aim: to investigate the potential for improving medium- and long-term outcomes of sling procedures for stress urinary incontinence using the transobturator placement of a prolene loop (TVT-Obturator, Tension-Free Vaginal Tape - Obturator, TVT-O) in combination with local estrogen therapy in postmenopausal women.
Materials and methods. A comparative study was conducted to evaluate the immediate and long-term outcomes of sling procedures for surgical correction of stress urinary incontinence in menopausal women. The study included two representative groups. Group I (n=28): Patients underwent free synthetic loop plasty (TVT) for stress urinary incontinence. Group II (n=30): Patients underwent TVT-O and received a course of natural and semi-synthetic estrogens (promestriene). Statistical data analysis was performed using SPSS 21.
Results. Two years post-surgery, patients in Group I had a significantly higher frequency of urgency and urge incontinence episodes compared to women in Group II. Additionally, the reduction in urinary incontinence episodes by ≥50% from baseline was significantly greater in Group II. At the two-year follow-up, a significantly higher number of women in Group II had a negative cough test and lower average pad weight. Moreover, the mean UDI-6 (Urogenital Distress Inventory) score in this group was significantly lower compared to Group I, indicating a more pronounced reduction in stress urinary incontinence symptoms.
Conclusions. The results of a two-year follow-up of menopausal patients after surgical treatment of stress urinary incontinence demonstrated that TVT-O surgery, in combination with a postoperative course of natural and semi-synthetic estrogen therapy (promestriene), is statistically significantly more effective than TVT surgery alone.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of participating institution. The informed consent of the patient was obtained for conducting the studies.
No conflict of interest was declared by the authors.
References
Abe T, Matsumoto S, Kunimoto M, Hachiro Y, Ota S, Ohara K et al. (2022). Prevalence of Double Incontinence and Lower Urinary Tract Symptoms in Patients with Fecal Incontinence: A Single-center Observational Study. J Anus Rectum Colon. 8(1): 30-38. https://doi.org/10.23922/jarc.2023-040; PMid:38313750 PMCid:PMC10831982
Atlı N, Kaplan Serin E. (2024). Prevention and management of urinary incontinence-associated dermatitis: A systematic review. J Tissue Viability. S0965-206X(24)00130-X. https://doi.org/10.1016/j.jtv.2024.08.006; PMid:39223059
Bjelic-Radisic Dorfer M, Greimel E, Frudinger A, Tamussino K, Winter R. (2006). Quality of life and continence 1 year after the tension-free vaginal tape operation. Am J Obstet Gynecol. 195(6): 1784-1788. https://doi.org/10.1016/j.ajog.2006.07.014; PMid:17132481
Bohadelnikova KI, Chaika KV, Yatsyna OI, Bondaruk VP, Fedko YeV, Bodnarchuk OV. (2024). Efficacy and safety of postoperative vaginal laser therapy in women with an implanted TVT-O sling for the treatment of stress urinary incontinence. Ukrainian Journal of Perinatology and Pediatrics. 4(100): 63-69. https://doi.org/10.15574/PP.2024.4(100).6369
Dugan SA, Crawford SL, Wente K, Waetjen LE, Karvonen-Gutierrez C, Harlow SD. (2024). The association of urinary incontinence and disability among a diverse sample of midlife Study of Women's Health Across the Nation women. Menopause. 31(1): 18-25. https://doi.org/10.1097/GME.0000000000002282; PMid:38016162 PMCid:PMC10766380
Eredics K, Wehrberger C, Edlinger L, Müller U, Rauchenwald M et al. (2023). Urinary Incontinence, Quality of Life, and Risk Factors in a Geriatric Cohort. Urol Int. 107(9): 866-871. https://doi.org/10.1159/000531582; PMid:37611548
Ford AA, Rogerson L, Cody JD, Aluko P, Ogah JA. (2017). Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 7(7): CD006375. https://doi.org/10.1002/14651858.CD006375.pub4; PMid:28756647 PMCid:PMC6483329
Harland N, Walz S, Eberli D, Schmid FA, Aicher WK, Stenzl A et al. (2023). Stress Urinary Incontinence: An Unsolved Clinical Challenge. Biomedicines. 11(9): 2486. https://doi.org/10.3390/biomedicines11092486; PMid:37760927 PMCid:PMC10525672
Huang P, Luo K, Wang C, Guo D, Wang S, Jiang Y. (2021). Urinary Incontinence Is Associated With Increased All-Cause Mortality in Older Nursing Home Residents: A Meta-Analysis. J Nurs Scholarsh. 53(5): 561-567. https://doi.org/10.1111/jnu.12671; PMid:34021695
Imamura M, Hudson J, Wallace SA, MacLennan G, Shimonovich M, Omar MI, (2019). Surgical interventions for women with stress urinary incontinence: systematic review and network meta-analysis of randomised controlled trials. BMJ. 365: l1842. https://doi.org/10.1136/bmj.l1842; PMid:31167796 PMCid:PMC6549286
Kobashi KC, Vasavada S, Bloschichak A, Hermanson L, Kaczmarek J, Kim SK et al. (2023). Updates to Surgical Treatment of Female Stress Urinary Incontinence (SUI): AUA/SUFU Guideline (2023). J Urol. 209(6): 1091-1098. https://doi.org/10.1097/JU.0000000000003435; PMid:37096580
Lee UJ, Feinstein L, Ward JB, Kirkali Z, Martinez-Miller EE et al. (2021). Prevalence of Urinary Incontinence among a Nationally Representative Sample of Women, 2005-2016: Findings from the Urologic Diseases in America Project. J Urol. 205(6): 1718-1724. https://doi.org/10.1097/JU.0000000000001634; PMid:33605795
Liu W, Qian L. (2024). Risk factors for postpartum stress urinary incontinence: a prospective study. BMC Urol. 24(1): 42. https://doi.org/10.1186/s12894-024-01430-x; PMid:38365685 PMCid:PMC10873983
Maggiore ULR, Agrò EF, Soligo M, Marzi VL, Digesu A, Serati M. (2017). Long-term outcomes of TOT and TVT procedures for the treatment of female stress urinary incontinence: A systematic review and meta-analysis. Int Urogynecol J. 28(8): 1119-1130. https://doi.org/10.1007/s00192-017-3275-x; PMid:28213797
Offiah I, Freeman R; MONARC™ study group. (2021). Long-term efficacy and complications of a multicentre randomised controlled trial comparing retropubic and transobturator mid-urethral slings: a prospective observational study. BJOG. 128(13): 2191-2199. https://doi.org/10.1111/1471-0528.16899; PMid:34478604
Rahn DD, Marinis SI, Schaffer JJ et аl. (2006). Anatomical path of the tension-free vaginal tape: reassessing current teaching. Am. J. Obstet. Gynecol. 195; 6: 1809-1813. https://doi.org/10.1016/j.ajog.2006.07.009; PMid:17132484
Sadri H, Oliaei A, Sadri S, Pezeshki P, Chughtai B, Elterman D. (2024). Systematic review and meta-analysis of urinary incontinence prevalence and population estimates. Neurourol Urodyn. 43(1): 52-62. https://doi.org/10.1002/nau.25276; PMid:37661792
Speights SE, Moore RD, Miklos JR. (2000). Frequency of lower urinary tract injury at laparoscopic burch and paravaginal repair. J Am Assoc Gynecol Laparosc. 7(4): 515-518. https://doi.org/10.1016/S1074-3804(05)60365-9; PMid:11044503
Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to safeguard women's health from deceptive health claims and significant risks related to devices marketed for use in medical procedures for «vaginal rejuvenation». URL: https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-efforts-safeguard-womens-health-deceptive-health-claims.
Wu JM. (2021). Stress Incontinence in Women. N Engl J Med. 384(25): 2428-2436. https://doi.org/10.1056/NEJMcp1914037; PMid:34161707
Yang X, Wang X, Gao Z, Li L, Lin H, Wang H et al. (2022). The Anatomical Pathogenesis of Stress Urinary Incontinence in Women. Medicina (Kaunas). 59(1): 5. https://doi.org/10.3390/medicina59010005; PMid:36676629 PMCid:PMC9865065
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ukrainian Journal of Perinatology and Pediatrics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “Ukrainian Journal of Perinatology and Pediatrics” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license(СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
